Estandarización de un modelo murino…
291
22. WHO, Guidelines for the treatment of
P. falciparum
malaria in
WHO Library cataloguing-‐in-‐
Publication Data
, Programme, G. M., Ed., World Health Organization Switzerland (2010).
23. Dondorp, A., Pathophysiology, clinical presentation and treatment of Cerebral Malaria,
Neurology Asia, 10
, 67 (2005).
24. Reis, P., Comim, C., Hermani, F., Silva, T., Barichello, T., Portella, A., Gomes, F., Sab, I.,
Frutuoso, V., Oliveira, M., Bozza, P., Pizzol, F., Zimmerman, G., Quevedo, J. and Neto, H.,
Cognitive Dysfunction is Sustained after Rescue Therapy in Experimental cerebral Malaria,
and is Reduced by Additive Antioxidant Therapy.,
PLOS pathogens 6
, 1 (2010).
25. Lou, J., Lucas, R. and Grau, G., Pathogenesis of Cerebral Malaria: Recent Experimental Data
and Possible Applications for Humans,
Clinical Microbiology Reviews, 14
, 810 (2001).
26. De Souza, B., Hafalla, J., Riley, E., Couper, K., Cerebral Malaria: why experimental murine
models are required to understand the pathogenesis of disease.,
Parasitology, 137
, 755
(2009).
27. Clemmer L., M. Y., Zanini G., Frangos A., Carvalho L. , Artemether and artesunate show the
highest efficacies in rescuing mice with late-‐stage cerebral malaria and rapidly decrease
leukocyte accumulation in the brain.,
Antimicrobial Agents and Chemotherapy., 55
, 1383
(2011).
28. Bienvenu A., F. J., Kaiser K., Latour C., Picot S., Artesunate -‐ Erythropoietin combination for
murine cerebral malaria treatment.,
Acta Tropica, 106
, 104 (2008).
29. Carvalho, L., Murine cerebral malaria: how far from human cerebral malaria? ,
TRENDS in
Parasitology, 26
, 271 (2010).
30. White, N., Turner, G., Medana, I., Dondorp, and A Day, N. , The murine cerebral malaria
phenomenon,
TRENDS in Parasitology, 26
(2009).
31. Kicska, G. A., T. Li-‐Min, V. L. Shramm, and K. Kim., Effect of dietary p-‐aminobenzoic acid on
murine
Plamodium yoelii
infection. ,
The Journal of Infectious Diseases, 188
, 4680 (2003).
32. Calderon, J., Bolaños, R., Carrillo, J., Escamilla, C., Salazar, S., Moreno, G. and Rivera, G.,
Behavioral analysis of the Reserpine induced motor changes in a Parkinsonian mouse
model. ,
Neuropsicología, Neuropsiquiatría y Neurociencias., 11
, 49 (2011).
33. Tadaiesky M., A. R., Vital M. , Different effects of 7-‐nitroindazole in reserpine-‐ induced
hypolocomotion in two strains of mice. ,
European Journal of Pharmacology, 535
, 199
(2006).
34. Lambertsen, C. J. B., PL. Drabkin, DL, Schimidt, C., Relationship of oxygen tension to
hemoglobin oxygen saturation in the arterial blood of normal men,
Journal Applied
Physiology, 1952
, 873 (1952).
35. Kozler, P. a. P., J., Altered Blood-‐Brain Barried Permeability and Its Effect on the
Distribution of Evans Blue and Sodium Fluoresce in the Rat Brain Applied by Intracarotid
Injection
Physiological Res arch 52
, 607 (2003).
36. Van der Heyde, H. N., J. Combes, V. Gramaglia, I. Grau, GE., A unified hypothesis for the
genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to
microcirculatory dysfunction. ,
TRENDS in Parasitology, 22
, 503 (2006).
37. Pongponratin, E., Turner, G., Day, N., Phu, N., Simpson, J., Stepniewska, K., Mai, N., Vejakul,
P., Looreesuwan, S., Hien, T., Ferguson, D. and White, N. , An Ultrastructural Study of the
Brain in Fatal
Plasmodium Falciparum
Malaria,
The American Society of Tropical Medicine
and Hygiene, 69
, 345 (2003).
38. Combes, V., De Souza, B., Rénia, L., Hunt, N. and Grau, G. , Cerebral Malaria: Which parasite?
which model? ,
Progress in Neurobiology, 91
, 140 (2006).
39. AQUAMAT, G., Artesunate versus Quinine in the treatment of severe
falciparum
malaria in
African children (AQUAMAT): an open-‐label, randomized trial. ,
The Lancet, 376
, 1647
(2010).
